A Sharma, B Sangameswaran, Vjain, M S Saluja. Hepatoprotective activity of Adina cordifolia against ethanol induce hepatotoxicity in rats. nternational Current Pharmaceutical Journal 2012, 1(9): 279-284.
Albano, E., Rundgren, M., Harvison, P. J., Nelson, S. D., & Moldeus, P. (1985). Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity. Molecular pharmacology, 28(3), 306-311.
Anand BS and Velez M (2000) Influence of chronic alcohol abuse on hepatitis C virus replication. Digestive Dis 18: 168-171.
Ao, Z. H., Xu, Z. H., Lu, Z. M., Xu, H. Y., Zhang, X. M., & Dou, W. F. (2009). Niuchangchih (Antrodia camphorata) and its potential in treating liver diseases. Journal of Ethnopharmacology, 121(2), 194-212.
Bardina LR, Satanovskaia VI, Pron'ko PS, Kuz'mich AB.( 1997) Activity of the enzymes of ethanol and acetaldehyde metabolism in rats with varying initial sensitivity to alcohol. Ukr Biokhim Zh,69(1)：94-99.
Beamer, N., Coull, B. M., Sexton, G., de Garmo, P., Knox, R., & Seaman,G. (1993). Fibrinogen and the albumin-globulin ratio in recurrent stroke. Stroke,24(8), 1133-1139.
Bellentani, S., Saccoccio, G., Costa, G., Tiribelli, C., Manenti, F., Sodde, M., & Dionysos Study Group. (1997). Drinking habits as cofactors of risk for alcohol induced liver damage. Gut, 41(6), 845-850.
Bergmeyer HU, Horder M, Rej R. Approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC Method for aspartate aminotransferase. J Clin Chem Clin Biochem 1986;24:497–508.
Bergmeyer HU, Hørder M, Rej R. Approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC Method for alanine aminotransferase. J Clin Chem Clin Biochem 1986;24:481–489.
Boffetta, P., & Hashibe, M. (2006). Alcohol and cancer. The lancet oncology,7(2),149-156.
Brobeck JR, ED. Physiological Basis of Medical Practice, 9th ed. Baltiomore, MD: Wilkins and Wilkins, 1973:4-7.
Begleiter, H., & Kissin, B. (Eds.). (1996).The pharmacology of alcohol and alcohol dependence (No. 2). Oxford University Press.
Cameron G.R., Karunaratne W.A.E.（1936）Carbon tetrachloride cirrhosis in relation to liver regeneration. J. Pathol. Bacteriol. 42:1-21.
Cameron, G. R., & Karunaratne, W. A. E. (1936). Carbon tetrachloride cirrhosis in relation to liver regeneration.The Journal of Pathology and Bacteriology,42(1), 1-21.
Cameron, G. R., & Karunaratne, W. A. E. (1936). Carbon tetrachloride cirrhosis in relation to liver regeneration. The Journal of Pathology and Bacteriology,42(1), 1-21.
Chang, T. T., & Chou, W. N. (1995). Antrodia cinnamomea sp. nov. on Cinnamomum kanehirai in Taiwan. Mycological Research,99(6), 756-758.
Chen, D. S., Hsu, N. H. M., Sung, J. L., Hsu, T. C., Hsu, S. T., Kuo, Y. T.,& Shih, Y. T. (1987). A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen—carrier mothers. Jama,257(19), 2597-2603.
Chen, J. J., Lin, W. J., Liao, C. H., & Shieh, P. C. (2007).Anti-inflammatory benzenoids from Antrodia camphorata.Journal of natural products,70(6), 989-992.
Cherng, I. H., Wu, D. P., & Chiang, H. C. (1996). Triterpenoids from Antrodia cinnamomeaPhytochemistry, 41(1), 263-267.
Cho, K. J., Yun, C. H., Yoon, D. Y., Cho, Y. S., Rimbach, G., Packer, L., & Chung, A. S. (2000). Effect of Bioflavonoids Extracted from the Bark of Pinus maritima on Proinflammatory Cytokine Interleukin-1 Production in Lipopolysaccharide- Stimulated RAW 264.7.Toxicology and applied pharmacology, 168(1), 64-71.
Cirrhosis of the liver.J.Pathol.Bacteriol. 64:53-60.
Clay, K. D., Hanson, J. S., Pope, S. D., Rissmiller, R. W., Purdum, P. P., & Banks, P. M. (2006). Brief communication: severe hepatotoxicity of telithromycin: three case reports and literature review. Annals of internal medicine, 144(6), 415-420.
Cohen G., Dembiec D., Marcus J.（1970）.Measurement of catalase in tissue extracts. Anal.Biochem. 34:30-38.
Cromie, S. L., Jenkins, P. J., Bowden, D. S., & Dudley, F. J. (1996). Chronic hepatitis C: effect of alcohol on hepatic activity and viral titre. Journal of hepatology, 25(6), 821-826.
Dahlin, D. C., Miwa, G. T., Lu, A. Y., & Nelson, S. D. (1984). N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proceedings of the National academy of Sciences, 81(5), 1327-1331.
Duan, Z. J., Li, L. L., Ju, J., Gao, Z. H., & He, G. H. (2006). Treatment of hyperbilirubinemia with blood purification in China. World Journal of Gastroenterology, 12(46), 7467.
Ehrlich P. Charite Amm 1883;8:140.
Eisenstein, A. B. (1982). Nutritional and metabolic effects of alcohol. Journal of the American Dietetic Association,81(3), 247-251.
Fischer, V., West, P. R., Nelson, S. D., Harvison, P. J., & Mason, R. P. (1985). Formation of 4-aminophenoxyl free radical from the acetaminophen metabolite .J Biol Chem. ,260(21):46-50.
N-acetyl-p-benzoquinone imine. Journal of Biological Chemistry, 260(21), 11446-11450.
Flora, K., Hahn, M., Rosen, H., & Benner, K. (1998). Milk thistle (Silybum marianum) for the therapy of liver disease. The American journal of gastroenterology, 93(2), 139-143.
Friedman, S. L. (2000). Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.Journal of Biological Chemistry,275(4), 2247-2250.
Garnero, P., & Delmas, P. D. (1993). Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. The Journal of clinical endocrinology & metabolism,77(4), 1046-1053.
Geethangili, M., & Tzeng, Y. M. (2011). Review of pharmacological effects of Antrodia camphorata and its bioactive compounds. Evidence-Based Complementary and Alternative Medicine,2011.
Goldman, L., & Schafer, A. I. (2011). Cecil Medicine: Expert Consult-Online. Elsevier Health Sciences.
Grant GH, Silverman LM, Christenson RH. Amino acids and proteins. In: Tietz NW, ed. Fundamentals of Clinical Chemistry, 3 rd edition Philadelphia, Pa: WB Saunders, 1987:328-330.
Greiling H, Gressner AM, eds. Lehrbuch der Klinischen Chemie und Pathobiochemie, 3 rd ed. Stuttgart/New York: Schattauer Verlag, 1995.
Hepatoprotective activity of methanolic extract of Barleria montana leaves in ethanol treated rats. Asian Pacific Journal of Tropical Disease 2012,S748-S752.
Hseu, Y. C., Chang, W. C., Hseu, Y. T., Lee, C. Y., Yech, Y. J., Chen, P. C., & Yang, H. L. (2002). Protection of oxidative damage by aqueous extract from Antrodia camphorata mycelia in normal human erythrocytes. Life Sciences,71(4), 469-482.
Hsiao G., Shen M.Y., Lin K.H., Lan M.H., Wu L.Y., Chou D.S., Lin C.H., Su C.H., and. Sheu J.R. Antioxidative and Hepatoprotective Effects of Antrodia camphorata Extract. J. Agric. Food Chem. 51, 3302-3308 (2003).
Hsiao, G., Shen, M. Y., Lin, K. H., Lan, M. H., Wu, L. Y., Chou, D. S., & Sheu, J. R. (2003). Antioxidative and hepatoprotective effects of Antrodia camphorata extract. Journal of Agricultural and Food Chemistry,51(11), 3302-3308.
Hsu, Y. L., Kuo, P. L., Cho, C. Y., Ni, W. C., Tzeng, T. F., Ng, L. T., & Lin, C. C. (2007). Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor κB pathway. Food and chemical toxicology,45(7), 1249-1257.
Hu M.L.（1994）.Measurement of plasma protein thiopls and GSH. Methods Enzymol.233:380-385.
Huang, G. J., Deng, J. S., Huang, S. S., Lee, C. Y., Hou, W. C., Wang, S. Y., ... & Kuo, Y. H. (2013). Hepatoprotective effects of eburicoic acid and dehydroeburicoic acid from Antrodia camphorate in a mouse model of acute hepatic injury.Food chemistry,141(3), 3020-3027.
Ikekawa, T. M. N. G. F., Nakanishi, M., Uehara, N., Chihara, G.,& Fukuoka, F. (1968). Antitumor action of some Basidiomycetes, especially Phllinus linteus.Gann Gan,59(2), 155-157.
Ingelman-Sundberg, M., Johansson, I., Yin, H., Terelius, Y., Eliasson, E., Clot, P., & Albano, E. (1993). Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol, 10(6), 447-452.
Internation Federation of Clinical Chemistry（IFCC）.1986a. J. Clin. Chem.Biochem. 24:481-495.
Internation Federation of Clinical Chemistry（IFCC）.1986b. J. Clin. Chem.Biochem. 24:497-510.
J. C. Chen, C. N. Chen, S. J. Sheu et al., “Liver-caring medicine containing Antrodia camphorata,” US 0113297-2003-6-19, 2003.
Chen, C. N., Chen, J. C., Chuang, C. H., Dai, Y. Y., Hu, M. L., Sheu, S. J., & Tsai, C. C. (2001). Liver-caring medicine containing Antrodia camphorate,.
Kao, J. H., & Chen, D. S. (2002). Global control of hepatitis B virus infection.The Lancet infectious diseases, 2(7), 395-403.
Karmen A. J Clin Invest 1955;24:126.
King EJ, Armstrong AR. Can Med Assoc J 1934;31:376.
Klein S. Protein-energy malnutrition. In: Goldman L, Schafer AI, eds. Cecil Medicine. 24th ed. Philadelphia, Pa: Saunders Elsevier; 2011:chap 222.
Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981 Sep-Oct;1(5):431-5.
Koff, R. S., & Dienstag, J. L. (1995, February). Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. InSeminars in liver disease (Vol. 15, No. 1, pp. 101-109).
Lee IH1, Huang RL, Chen CT, Chen HC, Hsu WC, Lu MK.( 2002 ). Antrodia camphorata polysaccharides exhibit anti-hepatitis B virus effects. FEMS Microbiol Lett. 19;209(1):63-7.
Lee, C. C., Yang, H. L., Way, T. D., Kumar, K. J., Juan, Y. C., Cho, H. J., & Hseu, Y. C. (2012). Inhibition of cell growth and induction of apoptosis by Antrodia camphorata in HER-2/neu-overexpressing breast cancer cells through the induction of ROS, depletion of HER-2/neu, and disruption of the PI3K/Akt signaling pathway. Evidence-Based Complementary and Alternative Medicine,2012.
Lee, I. H. R. L., Huang, R. L., Chen, C. T., Chen, H. C., Hsu, W. C., & Lu, M. K. (2002). Antrodia camphorata polysaccharides exhibit anti‐hepatitis B virus effects. FEMS Microbiology Letters,209(1), 63-67.
Lieber, C. S. (1985). Alcohol and the liver: metabolism of ethanol, metabolic effects and pathogenesis of injury. Acta Medica Scandinavica,218(S703), 11-55.
Lee, W. M. (2003). Drug-induced hepatotoxicity. New England Journal of Medicine, 349(5), 474-485.
Lettéron, P., Labbe, G., Degott, C., Berson, A., Fromenty, B., Delaforge, M., & Pessayre, D. (1990). Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice: evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant. Biochemical pharmacology,39(12), 2027-2034.
Lieber C.S.（1997） Role of oxidative stress and antioxidant therapy in alcoholic and non alcoholic liver diseases. Adv Pharmacol 38:601.
Lieber CS (1985) Alcohol and the liver: metabolism of ethanol, metabolic effects and pathogenesis of injury. Acta Med Scand Suppl 703: 11-55.
Lieber CS (1994) Hepatic and metabolic effects of ethanol: pathogenesis and prevention. Ann Med 26: 325-330.
Lieber, C. S., Leo, M. A., Cao, Q., Ren, C., & DeCarli, L. M. (2003). Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons.Journal of clinical gastroenterology,37(4), 336-339
Lin, J.Y., Wu, T.Z. & Chou, J.C. (2006). In vitro induction of fruiting body in Antrodia cinnamomea-a medicinally important fungus. Botanical Studies, 47(3), 267-272.
Lin, J.Y., Wu, T.Z. & Chou, J.C. (2006). In vitro induction of fruiting body in Antrodia cinnamomea-a medicinally important fungus. Botanical Studies, 47(3), 267-272.
Lin, S. C., Lin, C. H., Lin, C. C., Lin, Y. H., Chen, C. F., Chen, I. C., & Wang, L. Y. (2002). Hepatoprotective effects ofArctium lappa linne on liver injuries induced by chronic ethanol consumption and potentiated by carbon tetrachloride. Journal of Biomedical Science, 9(5), 401-409.
Lin, T. Y., Chen, C. Y., Chien, S. C., Hsiao, W. W., Chu, F. H., Li, W. H., & Wang, S. Y. (2011). Metabolite profiles for Antrodia cinnamomea fruiting bodies harvested at different culture ages and from different wood substrates.Journal of agricultural and food chemistry,59(14), 7626-7635.
Liu, D. Z., Liang, H. J., Chen, C. H., Su, C. H., Lee, T. H., Huang, C. T., & Liang, Y. C. (2007). Comparative anti-inflammatory characterization of wild fruiting body, liquid-state fermentation, and solid-state culture of Taiwanofungus camphoratus in microglia and the mechanism of its action.Journal of ethnopharmacology,113(1), 45-53.
Llop Romero, E., Hirsch Birn, S., De la Maza C, M. P., Bunout Barnatt, D., Iturriaga Ruiz, H., Silva A, C., & Rothhammer Engel, F. (1995). El sistema mayor de histocompatibilidad como factor de riesgo de la enfermedad hepática alcohólica. Rev. méd. Chile, 123(6), 687-93.
Lutz W. D., & Meinrad B. (2003). Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. CRC critical reviews in toxicology,33(2), 105-136.
Mandl, J., Bánhegyi, G., Kalapos, M. P., & Garzó, T. (1995). Increased oxidation and decreased conjugation of drugs in the liver caused by starvation. Altered metabolism of certain aromatic compounds and acetone. Chemico-biological interactions, 96(2), 87-101.
Marshall WJ, ed. (1989)Illustrated Textbook of Clinical Chemistry, 3 rd ed. London: Gower Medical Publishing, :207-218.
Mason, R. P., & Fischer, V. (1986, September). Free radicals of acetaminophen: their subsequent reactions and toxicological significance. InFederation proceedings (Vol. 45, No. 10, pp. 2493-2499).
Matsuzaki S and Lieber CS (1977) Increased susceptibility of hepatic mitochondria to the toxicity of acetaldehyde after chronic ethanol consumption. Biochem Biophys Res Commun 75: 1059-1065.
Melin, A. M., Perromat, A., & Clerc, M. (1996). In vivo effect of diosmin on carrageenan and CCl4‐induced lipid peroxidation in rat liver microsomes.Journal of biochemical toxicology,11(1), 27-32.
Meyer, U. A. (1996). Overview of enzymes of drug metabolism. Journal of pharmacokinetics and biopharmaceutics, 24(5), 449-459.
Miller, M. G., & Jollow, D. J. (1987). Relationship between sulfotransferase activity and susceptibility to acetaminophen-induced liver necrosis in the hamster. Drug metabolism and disposition, 15(2), 143-150.
Mizuno, T. (1995). Bioactive biomolecules of mushrooms: food function and medicinal effect of mushroom fungi. Food Reviews International,11(1), 5-21.
Morgan M.Y., Sherlock S.（1977）Sex related differences among 100patients with alcoholic liver disease. Br. Med. J. 1:939.
Mourelle, M., Muriel, P., Favari, L., & Franco, T. (1989). Prevention of CCL4-induced liver cirrhosis by silymarin. Fundamental & clinical pharmacology, 3(3), 183-191.
Muriel, P., & Escobar, Y. (2003). Kupffer cells are responsible for liver cirrhosis induced by carbon tetrachloride.Journal of Applied Toxicology,23(2), 103-108.
Nelson, S. D. (1990, November). Molecular mechanisms of the hepatotoxicity caused by acetaminophen. In Seminars in liver disease (Vol. 10, No. 4, pp. 267-278).
Ohmori Y. Enzymologia 1937;4:217.
Orrenius, S., Thor, H., & Jernstrom, B. (1980). The influence of inducers on drug-metabolizing enzyme activity and on formation of reactive drug metabolites in the liver. In Environmental Chemicals, Enzyme Function and Human Disease. Ciba Foundation Symposium (Vol. 76, p. 25).
Pirmohamed, M., Kitteringham, N. R., & Park, B. K. (1994). The role of active metabolites in drug toxicity. Drug Safety, 11(2), 114-144.
Potter, D. W., & Hinson, J. A. (1989). Acetaminophen peroxidation reactions.Drug metabolism reviews, 20(2-4), 341-358.
Role of reactive oxygen species secreted by activated Kupffer cells in the potentiation of carbon tetrachloride hepatotoxicity by hypervitaminosis A.in: Wisse E., Knook D.L.,40McCuskey R.S.（Eds.）.Cells of the Hepatic Sinusoid, Vol. 2, Kupffer Cell Foundation,Rijwijik,pp. 376-379.
Ruwart MJ, Wilkinson KF, Rush BD, Vidmar TJ, Peters KM, Henley KS, Appelman HD, Kim KY, Schuppan D, Hahn EG. The integrated value of serum procollagen III peptide over time predicts hepatic hydroxyproline content and stainable collagen in a model of dietary cirrhosis in the rat. Hepatology. 1989 Nov;10(5):801-6.
Saller, R., Meier, R., & Brignoli, R. (2001). The use of silymarin in the treatment of liver diseases. Drugs, 61(14), 2035-2063.
Schmidt FW. Ref Med Ges, Marburg/Lahn, December 1959.
Seachrist, J. L., Loi, C. M., Evans, M. G., Criswell, K. A., & Rothwell, C. E. (2005). Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity. Toxicological Sciences, 88(2), 551-561.
Seitz, H. K., & Stickel, F. (2007). Molecular mechanisms of alcohol-mediated carcinogenesis.Nature Reviews Cancer,7(8), 599-612.
Shanaz Banu, Arunachalam G, Jayaveera KN, Ashoka Babu VL, Vimal Kumar.
Sipes, I. G., Elsisi, A. E., Sim, W. W., Mobley, S. A., & Earnest, D. L. (1989). Role of reactive oxygen species secreted by activated Kupffer cells in the potentiation of carbon tetrachloride hepatotoxicity by hypervitaminosis A.Cells of the hepatic sinusoid,2, 376-379.
Smocovitis, V. B. (2000). Proteins, Enzymes, Genes: The Interplay of Chemistry and Biology. JAMA: The Journal of the American Medical Association, 283(13), 1754-1754.
Song, T. Y., & Yen, G. C. (2002). Antioxidant properties of Antrodia camphorata in submerged culture.Journal of Agricultural and Food Chemistry,50(11), 3322-3327.
Song, Z., Deaciuc, I., Song, M., Lee, D. Y. W., Liu, Y., Ji, X., & McClain, C. (2006). Silymarin Protects Against Acute Ethanol‐Induced Hepatotoxicity in Mice. Alcoholism: Clinical and Experimental Research, 30(3), 407-413.
Talamonti, M. S., & Pappas, S. G. (Eds.). (2001). Liver-Directed Therapy for Primary and Metastatic Liver Tumors (Vol. 109). Springer.
Tamayo R.P.（1983）Is cirrhosis of the liver experimentally produced by CCl4 an adequate model of human cirrhosis? Hepatology. 3:112-120.
Tietz NW. J Clin Chem Clin Biochem 1983;21:731–748.
Tsai, Z. T. L., S. L. (1982). " The use and the effect of Ganoderma." Sheng-Tun Publisher: Taichung, Taiwan: 116-7.
Tatsumi, S., Mabuchi, T., Abe, T., Xu, L., Minami, T., & Ito, S. (2004). Analgesic effect of extracts of Chinese medicinal herbs Moutan cortex and Coicis semen on neuropathic pain in mice. Neuroscience letters, 370(2), 130-134.
Tsukuma, H., Hiyama, T., Tanaka, S., Nakao, M., Yabuuchi, T., Kitamura, T., & Kawashima, T. (1993). Risk factors for hepatocellular carcinoma among patients with chronic liver disease. New England journal of medicine, 328(25), 1797-1801.
Kawashima, T. (1993). Risk factors for hepatocellular carcinoma among patients with chronic liver disease. New England journal of medicine,328(25), 1797-1801.
Victor M., Piñeiro-Carrero, and Piñeiro E.O. (2004) Liver. Pediatrics 113 (4): 1097-1106 .
Victor M., Piñeiro-Carrero, and Piñeiro E.O. Liver. Pediatrics 113 (4): 1097-1106 (2004)
Vogel, G., Tuchweber, B., Trost, W., & Mengs, U. (1984). Protection by silibinin against Amanita phalloides intoxication in beagles.Toxicology and applied pharmacology,73(3), 355-362.
Wahlefeld AW, Herz G, Bernt E. Modification of the Malloy-Evelyn method for a simple, reliable determination of total bilirubin in serum. Scand J clin Lab Invest 1972;29 .
Supplement 126:Abstract 11.12.
Wang, N., Li, P., Wang, Y., Peng, W., Wu, Z., Tan, S., ... & Su, W. (2008).
Hepatoprotective effect of Hypericum japonicum extract and its fractions.Journal of ethnopharmacology,116(1), 1-6.
Weber LW, Boll M and Stampfl A (2003) Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model Crit Rev Toxicol 33: 105-136.
Weber, L. W., Boll, M., & Stampfl, A. (2003). Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model.CRC critical reviews in toxicology,33(2), 105-136.
Weichselbaum TE. Amer J Clin Path 1946: 16:40.
Wroblewski F, LaDue JS. Ann Intern Med 1956;45:801.
Xu, C., Li, C. Y. T., & Kong, A. N. T. (2005). Induction of phase I, II and III drug metabolism/transport by xenobiotics. Archives of pharmacal research, 28(3), 249-268.
Yan, Z., & Caldwell, G. W. (2001). Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery. Current topics in medicinal chemistry,1(5), 403-425.
Yang, H. L., Hseu, Y. C., Chen, J. Y., Yech, Y. J., Lu, F. J., Wang, H. H., & Wang, B. C. (2006). Antrodia camphorata in submerged culture protects low density lipoproteins against oxidative modification. The American journal of Chinese medicine, 34(02), 217-231.
Yeh, C. T., Rao, Y. K., Yao, C. J., Yeh, C. F., Li, C. H., Chuang, S. E., .& Tzeng, Y. M. (2009). Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells. Cancer letters,285(1), 73-79.
Yokoyama, H., Goshima, S., Wada, T., Takaeda, M., Furuichi, K., Kobayashi, K. I., & Kida, H. (1999). The short-and long-term outcomes of membranous nephropathy treated with intravenous immune globulin therapy. Nephrology Dialysis Transplantation, 14(10), 2379-2386.
Zhang P., Bagby G.J., Xie M., Stoltz D.A., Summer W.R., Nelson S.（1998）.Acute ethanol intoxication inhibits neutrophil beta2- integrin expression in rats during endotoxemia. Alcoholism: Clinical & Experimental Research.22(1):135-41.
Zhu, Y. Z., Huang, S. H., Tan, B. K. H., Sun, J., Whiteman, M., & Zhu, Y. C. (2004). Antioxidants in Chinese herbal medicines: a biochemical perspective.Natural product reports,21(4), 478-489.
水野卓和川合正允著，賴慶亮譯 (1997) 菇類的化學，生化學。國立編譯館。
牛樟生物學及育林技術研討會論文集。林業叢刊第72 號。133-137。
王伯徹、陳啟楨、華傑 (1998) 食藥用菇類的培養與應用. 財團法人食品工業發展研究所。144-150。
吳青柳,常宏傳, & 黃劍銘 (2012) Phenytoin 引起的肝毒性案例報告。臺灣臨床藥學雜誌, 20(3), 261-270。
李順來（2009）台灣國寶-牛樟芝。台南縣：世貿出版社。
李聖慧, 吳龍源, 徐曉萍, 曾惠芬, 程景章, 施純全, & 邱雲棕. (2006). 大鼠肝損傷動物模式於中醫傳統方劑柴胡疏肝散變方之抗氧化及細胞色素評估。臺灣獸醫誌 32(3)：186-194.
李亦品（2006）以酒精與四氯化碳誘導肝損傷動物模式評估護肝功能之研究，台北醫學大學碩士論文。
林恭儀, 曹永昌, & 邱仲峯 (2013) 牛樟芝的傳統與現代用藥考據. 北市中醫會刊,19(2), 13-18.
洪千茵、徐兆谷、李敏齡（2012）淺談酒精濫用之風險及戒酒藥物。藥學雜誌 28(1)：141-145。
徐世寧.(2006) 藥物誘發的肝毒性。三總藥訊，7：1-11。
徐承毓 (2012). Terbinafine 導致的藥物性肝損傷: 一病例報告及文獻回顧。內科學誌, 23(2), 130-136.
張中姿、陳俊憲、林文鑫、陳勁初、呂鋒洲 (2001) 深紅色樟芝菌絲體之甲醇萃取物對肝癌細胞株之研究。中華民國食品科學技術學會第三十一次會員大會論文摘要。
張家蓓. (2012). 從藥食同源談肝病飲食宜忌。北市中醫會刊, 18(1), 50-59.
張隆仁 (2009) 保肝用途之營養保健與藥用植物水飛薊(奶薊)。豐年，59(4)，49-52
陳勁初 (2006) 樟芝功能性和安全性研究，博士論文，清華大學生命科學系。陳啟佑(2000)。酒與藥物之交互作用。高醫醫訊月刊20(5)，45。
陳清農、許勝傑、陳勁初 (2000) 紅色旋風勢不可擋。鄉間小路:48- 50。
陳榜. (2004). 慢性肝炎。中國中醫臨床醫學雜誌, 10(3), 216-222.
陳啓楨, 蘇慶華, & 藍明煌. (2001). 樟芝固體栽培及其生物活性之研究. Fungal Science, 16(1&2), 65-72.
黃君雁，（2010）台灣-牛樟芝的傳奇。農業學期刊。1-8。
黃啟彰（2001）β-胡蘿蔔素對於大白鼠酒精性肝臟疾病脂影響，台北醫學大學碩士論文。黃鈴娟 (2000) 樟芝與姬松茸之抗氧化性質及其多醣組成分析，碩士論文，國立中興大學食品科學系。
劉俊仁 (2002) 中草藥抗癌機制研究:(壹):黃芩素及黃芩苷對血管新生作用之影響及其機制探討;(貳):樟芝活性多醣體之生物活性分析及其經由免疫調節抑制腫瘤生長之研究，博士論文，國立臺灣大學生物化學暨分子生物學研究所。劉振軒、何逸遷、張文發、祝志平、王綉真(1996) H&E染色。組織病理染色技術與圖譜，第86-89頁。養研所，竹南。
蔡昌豪、董雪娟 (2008). 酒精與肝損傷。中華老年醫學雜誌 27(3)：238-241。
衛生福利部 (2013) 健康食品之護肝功能評估方法(針對化學性肝損傷)。台北：行政院衛生署公告。
鄭人慈、蕭淑珍、江吉文、戴慶玲 (2008) Silymarin於肝臟疾病之治療：臨床應用與實證結果。24(3)：129-134。
賴慶亮譯，水野卓、川合正允原著。1997。菇類的化學、生化學。國立編譯館。
臨床化學--原理與實驗 何敏夫主編 合記圖書出版 。1994年4 月。
簡秋源、姜宏哲、陳淑貞 (1997) 牛樟菇培養性狀及其三萜類成分分析之研究。
簡淑慧 .(2011) 何謂肝炎。取自http://www.vhct.gov.tw/index.php?mo=HealthInfo&ac=health3_show&sn=449
蘇慶華 (2013) 台灣特有國寶牛樟芝。52(7)：8-17。